Openbookopenbook
Equity
Jinxin Fertility Group Limited(JXFGF)
USD --+0.00%
Reward56Moderate
Risk45Moderate
📊75%Data
Thin -36% profit margin · Revenue down 11% YoY
JXFGF
+0.0 · +0.00%
USD · PINK
Jinxin Fertility Group Limited | Healthcare
Balanced
Market Cap:858.98M
ℹ️
Reward Rating
56
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
45
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on JXFGF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Jinxin Fertility Group Limited?

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States.

JXFGF · Verdict

Solid reward · moderate risk

JXFGF stands out on cash flow and valuation, but watch the balance sheet signal.

Based on 88% data coverage

JXFGF · Verdict

What’s working & what to watch

Strengths 2

  • Cash flow77/100

    13% free-cash-flow margin

  • Valuation65/100

    P/E 7.2×

Watchouts 1

  • Balance sheet41/100

    Interest covered 7.8×

Model-based scoring. For information only — not financial advice.

What is Jinxin Fertility Group Limited?

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. It offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 858.98M.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Profitability metrics are mixed — margins may be under pressure.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (56)

The scoring profile indicates moderate reward potential, with valuation and growth as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap858.98M
P/E RatioN/A
Dividend YieldN/A
52 Week High0.29
52 Week Low0.2
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding3B
No. of Employees3,365
IndustryMedical Care Facilities
ExchangePINK
Beta0.931
CurrencyUSD · Reports in CNY
Websitewww.jxr-fertility.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.